NCT00188877View on ClinicalTrials.gov

Intensity Modulated Radiation Therapy for Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2019

Conditions
Nasopharyngeal Neoplasms
Interventions
PROCEDURE

intensity modulated radiation therapy

DRUG

cisplatinium and fluorouracil - standard treatment

Trial Locations (1)

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT00188877 - Intensity Modulated Radiation Therapy for Head and Neck Cancer | Biotech Hunter | Biotech Hunter